About Cardlytics (NASDAQ:CDLX)
Cardlytics, Inc. is engaged in developing a purchase intelligence platform. The Company delivers relevant and measurable marketing analysis with purchase data from over financial institutions. The purchase data includes debit, credit, and bill pay data from online and in-store transactions. It helps the marketers identify, reach and influence likely buyers at scale, and measure the impact of marketing spends. The Company also operates an advertising channel, Cardlytics Direct. Cardlytics Direct delivers tailored marketing for marketers and financial institutions (FI). It provides personalized offers and suggestions for FI consumers on their purchase.
Industry, Sector and Symbol
Industry BUSINESS SERVICES
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Annual Sales$130.37 million
Price / Sales2.50
Price / CashN/A
Price / BookN/A
Return on EquityN/A
Return on AssetsN/A
Cardlytics (NASDAQ:CDLX) Frequently Asked Questions
What is Cardlytics' stock symbol?
Cardlytics trades on the NASDAQ under the ticker symbol "CDLX."
Where is Cardlytics' stock going? Where will Cardlytics' stock price be in 2018?
5 equities research analysts have issued 12-month price objectives for Cardlytics' stock. Their forecasts range from $19.00 to $25.00. On average, they anticipate Cardlytics' stock price to reach $22.40 in the next year. View Analyst Ratings for Cardlytics.
Who are some of Cardlytics' key competitors?
Some companies that are related to Cardlytics include Atento (ATTO), RR Donnelley & Sons (RRD), Barrett Business Services (BBSI), NV5 Global (NVEE), Heidrick & Struggles International (HSII), STHREE (STREF), RPX (RPXC), B. Riley Financial (RILY), Resources Connection (RECN), The Hackett Group (HCKT), InnerWorkings (INWK), Wandisco (WANSF), Everi (EVRI), Crawford & Company (CRD.B), National CineMedia (NCMI), Vectrus (VEC), CRA International (CRAI) and MDC Partners (MDCA).
Who are Cardlytics' key executives?
Cardlytics' management team includes the folowing people:
- Scott Grimes, Chief Executive Officer, Co-Founder and Director
- Lynne Laube, Co-Founder, Chief Operating Officer, Director
- David Evans, Chief Financial Officer & Head of Corporate Development
- Dani Cushion, Chief Marketing Officer
- Fred Rolle, Chief Strategy Officer & President, Bank Programs
When did Cardlytics IPO?
(CDLX) raised $76 million in an initial public offering (IPO) on Friday, February 9th 2018. The company issued 5,400,000 shares at $13.00-$15.00 per share. BofA Merrill Lynch and J.P. Morgan acted as the underwriters for the IPO and Wells Fargo Securities, SunTrust Robinson Humphrey, Raymond James and KeyBanc Capital Markets were co-managers.
When did Cardlytics' quiet period expire?
Cardlytics' quiet period expired on Wednesday, March 21st. Cardlytics had issued 5,400,000 shares in its public offering on February 9th. The total size of the offering was $70,200,000 based on an initial share price of $13.00. During Cardlytics' quiet period, underwriters and any insiders involved in the IPO were restricted from issuing any earnings forecasts or research reports for the company because of regulations issued by the Securities and Exchange Commission. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.
Has Cardlytics been receiving favorable news coverage?
Headlines about CDLX stock have been trending somewhat positive this week, according to Accern. The research group identifies negative and positive media coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Cardlytics earned a media sentiment score of 0.08 on Accern's scale. They also assigned headlines about the company an impact score of 45.45 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the next few days.
How do I buy shares of Cardlytics?
Shares of CDLX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Cardlytics' stock price today?
One share of CDLX stock can currently be purchased for approximately $16.28.
How big of a company is Cardlytics?
Cardlytics has a market capitalization of $331.93 million and generates $130.37 million in revenue each year. Cardlytics employs 342 workers across the globe.
How can I contact Cardlytics?
Cardlytics' mailing address is 675 PONCE DE LEON AVENUE NE SUITE 6000, ATLANTA GA, 30308. The company can be reached via phone at 888-798-5802 or via email at [email protected]
MarketBeat Community Rating for Cardlytics (CDLX)MarketBeat's community ratings are surveys of what our community members think about Cardlytics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Earnings History for Cardlytics (NASDAQ:CDLX)
No earnings announcements for this company have been tracked by MarketBeat.com
Cardlytics (NASDAQ:CDLX) Earnings Estimates
2018 EPS Consensus Estimate: ($1.86)
2019 EPS Consensus Estimate: ($0.76)
(Earnings estimates data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Dividend History for Cardlytics (NASDAQ:CDLX)
No dividend announcements for this company have been tracked by MarketBeat.com
Cardlytics (NASDAQ CDLX) Insider Trading and Institutional Ownership History
Cardlytics (NASDAQ CDLX) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|2/13/2018||David Thomas Evans||CFO||Buy||1,500||$13.00||$19,500.00|| |
|2/13/2018||Scott D Grimes||CEO||Buy||2,600||$13.00||$33,800.00|| |
Cardlytics (NASDAQ CDLX) News Headlines
Cardlytics (NASDAQ:CDLX) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Cardlytics (NASDAQ CDLX) Stock Chart for Thursday, March, 22, 2018